ALLIES Life Sciences Working Group

Draft Business Plan 2010/13

Prepared by: Lorraine Glen, Project Manager, Scotlands Colleges Dr David Gourley, Head of Centre for Science and Engineering, Dundee College June 2010

Paper 2.1

Contents
Executive Summary .................................................................................................................................. 1 Objectives .................................................................................................................................................. 1 Product....................................................................................................................................................... 2 Background ............................................................................................................................................... 3 Opportunity ................................................................................................................................................ 3 Marketing Opportunity and Strategy........................................................................................................ 4 Competition ............................................................................................................................................... 7 Financial Summary ................................................................................................................................... 7 Management Structure ............................................................................................................................. 8 Appendix A - Target Companies ....9 Appendix B - UK Trade & Investment - OMIS Report.... Appendix C - Education UK Scotland - Identifying New Markets ... Appendix D - Financial Plan ..... Appendix E - Training & Development Catalogue ....

Paper 2.1

Executive Summary
Scotlands Colleges Life Sciences Partnership (SCLSP) has identified a commercial opportunity to provide training to companies and training organisations in India. This opportunity will raise the profile of the colleges in Scotland through the SCI brand and generate a revenue stream during the current economic crisis. SCLSP is set apart from other providers through its partnership approach to training solutions, offering the expertise and experience of not just one provider but drawing on the combined resources and capability of Scotlands internationally recognised TVET colleges. The life science sector in India is a rapidly emerging industry with a highly educated community of scientists and researchers, strong government support and a growing infrastructure base. It is estimated to contribute 15% to the national GDP. Indias pharmaceutical industry is the third largest in the world in terms of volume and accounts for 10% of the worlds production with an estimated value of US$4.5B. Many multinational companies are locating manufacturing and research bases in collaborations with established Indian companies to produce new drugs and vaccines as well as working on bioinformatics. In addition there is an established generic manufacturing industry both for pharmaceutical products and medical devices. According to a recently commissioned UK Trade & Investment (UKTI) report there are over 20,000 pharmaceutical units active in the market and there are over 370 biotechnology companies. There is a perception that Indian Contract Manufacturers and Research Organisations (CMOs and CROs) suffer from a higher than acceptable level of failures with respect to quality and the industry is taking steps to address this perception. This creates a training opportunity which is not being fully met by existing providers. Over the past decade, Scotlands colleges have contributed to the success of Scotlands life science sector through the provision of innovative technical training and workforce development services. Now, Scotlands colleges are working in partnership to offer this expertise in education and training to international markets. The SCLSP are bringing to market a suite of teaching, training and consultancy offerings that can be tailored to meet the requirements of clients in all life science sectors. This business plan outlines the market, opportunities, costs and returns of establishing SCI operations in India and potentially in other regions.

Objectives
The SCLSP have considered the core products and markets and have a firm belief in the potential of offering in the Indian market. They intend to progress their collaborative venture by: 1. sending two targeted trade missions to be carried out by February 2011 with expected 10 leads for follow-up 2. establish funding support for the development of new business beyond the ALLIES funding period by December 2010 3. establish one collaborative business project with a partner in India by February 2011 to be funded through development/aid funding 4. develop and deliver two commercial collaborative projects by June 2012 5. investigate the establishment of an in-country office by June 2012

6. repeat success in other markets such as China, Brazil, South Africa, UAE where there are emerging life science sectors but a lack of training opportunities. Identify which of these markets and carry out two further targeted trade missions by December 2012.

Current Plan for Resources

Business will be shared amongst partners using the ALLIES model for collaboration and business can be carried out in-country supported by the eLearning available through the Scottish Colleges Biotechnology Consortium (SCBC) website. Any income will be returned to delivery partners on a unit basis at the agreed price with the customer. Development funds will cover expenditure incurred. The partnership has a budget of 10k available for trade missions through ALLIES and this will be used to part-fund the two missions. Additionally, Education UK Scotland (EDUKS) have been able to identify a budget of 5k to support the first mission in September 2010. This will enable 4-5 staff from the partnership to go on this first mission with little additional expense to their own organisations. The second mission will require colleges to fund the balance of mission costs themselves. In terms of staff resource for the missions, SCLSP have four expressions of interest so far for the September 2010 mission. Ongoing, partners are each willing to supply a minimum of one member of staff to carry out two weeks worth of training in India in support of development funded projects that will be based around capacity building of teaching staff at educational institutes in the first year after the ALLIES project ends. Staff resource for development projects is expected to be match funded. They have established a base costing rationale for development and commercial business projects and have agreed likely business projections over three years. The three year financial plan is supported by clearly articulated assumptions and they expect a positive contribution to overheads for the group by year three of 19,810. With added investment to cover development costs incurred by colleges to gain market entry, this surplus would be 105,210.

Product
The SCLSP is committed to the development and delivery of accredited curricula and specialised training for the life science industry. All the partners have good experience in the life science industries and working together they can help both industry and education institutes to develop, sharing experience, processes, procedures and developing change through education and training. These training programmes are designed to improve the operational efficiency and effectiveness of people working in the life science industry. They give employees the opportunity to improve their skill base and qualifications thus enhancing job satisfaction and career prospects. The training helps the employer develop and improve the skills and job flexibility of their employees which in turn leads to improved motivation and increased staff retention. The partnership will offer a comprehensive portfolio of training solutions for life science in the following areas: academic qualifications technical training and vocational qualifications consultancy and business solutions workforce development and executive education for industry.

From the catalogue they have selected two flagship programmes that they consider most marketable:

 Life Science Technician Graduate Conversion Course Modern Apprentice Programme in Life Science.

Background
Scotlands colleges have a long history of engaging with industry to provide technical and vocational education and training. By providing highly relevant and effective knowledge and skills, the colleges have supplied the technicians and craftsmen for Scotlands flagship industries. Scotland hosts one of the most sizeable life sciences clusters in Europe, with a significant multinational presence in research and development, and manufacturing. Scottish excellence in life sciences is recognised across the globe exemplified by its recognition by FierceBiotech as one of the global top five innovative regions for biotech. The prime function of the college sector in Scotland is to provide a quality of education and training that prepares students for the world of work. Colleges are looking overseas to offer services through developing partnerships that complement their core ethic of developing sustainable education provision that focuses on learner development. Our service is sustainable for international partners because we aim to support our educators in other countries to build capacity to deliver these services for themselves. We recognise the global demand, particularly in developing markets, to produce increased numbers of workplace ready graduates in order to achieve and maintain a competitive edge. Our colleges excel in developing learners - both competent in the skills of a specific role or business but also equipped to handle new learning as that role or business evolves.

Opportunity
Scotlands colleges have been successfully delivering skills training to and for the life science industry in Scotland both as individual institutions and in collaboration with other partners. Due to the partnership developments afforded through the ALLIES project, Scotlands colleges can now translate this expertise and experience into the global market. International markets are immense and making an impact as a single provider can be costly and inefficient. The SCLSP is working in collaboration to deliver industry aligned portfolios of education and training services because: Capacity to deliver quality teaching at home and abroad is limited. Sharing opportunities that a college cannot respond to provides a larger resource pool and ensures the customer needs are met. Confidence is increased when members can share the responsibility and pool experience and expertise in teaching; international business prospecting; and markets. Together we are stronger. Continuous Professional Development of staff in all participating colleges develops college experience and experience across the sector in Scotland and gives colleges leverage with key stakeholders including Scottish Government, Scottish Development International, SCDI, UKTI etc. Corporate CV of Scotlands colleges globally is enhanced through an ability to manage larger and more diverse business projects and will yield increased business prospects and ability to obtain funding support. Co-opitition with other colleges producing complementary or related products can lead to expansion of the market and the formation of new business relationships and creation of new forms of enterprise. The UK Life Science Marketing Board has identified four major markets for life sciences being Japan, India, China and the USA. Based on the UKTI report and existing contacts the decision

has been made to target India initially with other countries with emerging life science sectors at a later date as funds allow. Initial assessment of the experience and knowledge of the partners in international markets together with evidence from scanning secondary research over developing global markets for life sciences has led the partnership to focus on India as the main market to target for our services.

Marketing Opportunity and Strategy

Market Plan
The SCLSP will develop operations in a staged way: 1. identify target clients and partners through market intelligence already received and with the assistance of SDI and EDUKS introductions 2. trade missions that are part-funded by ALLIES to develop business relationships with education and training partners; industry based clients and strategic relationships with regional Governments who may look to overseas colleges to develop capacity of their institutes and local industry. They plan to undertake these missions in September 2010 with a follow-up in February 2011 3. undertake development funded collaborative projects in order to cultivate partnerships with education and training providers who may in future be converted to delivery partners. We are looking to scope our first development funded project with an education partner in India by February 2011 4. target identified corporate clients using business introductions services through SDI beginning in July 2010 5. Raise the profile of SCLSP services and our home based provision through overseas contacts and partners in order to yield additional student recruitment.

Target Market Analysis

Life sciences in India is an emerging industry with a highly educated community of scientists and researchers, strong government support and a growing infrastructure base. In recent years, there have been several major multinational companies who have established subsidiaries in India. US and European companies are collaborating with Indian firms to develop new drugs and vaccines, to conduct clinical trials and toxicity studies, to perform molecular modelling and lead optimisation, to provide computer services such as bioinformatics, and to develop industrial production processes for new drug ingredients. Indian companies are targeting the global biopharmaceutical outsourcing market. These companies are increasingly moving into the developed market and transitioning from bulk drugs to formulation exports. India will not only be accessing the generics market, but the research focus of many large companies has shifted toward the discovery of new chemicals-providing the skill set necessary for upstream outsourcing. Several of Indias largest companies have acquired US companies to gain a foothold in the US markets and gain technical and scientific expertise. Ranbaxy acquired ohm Labs (US), Dr Reddys acquired Trigenics (US), Sun Pharma acquired Able Labs and Careco (both US), Orchid acquired Bexel Pharma (US) and Biocon acquired Nobex (US). There are as many as 800 biotechnology companies active in the market, up to 50 of those companies work on advanced biotechnology applications. The industry was valued at US$3.7 billion and is expected to grow to US$6.7 billion by 2010. In terms of volume the Indian biotech business is ranked 4th in the world.

Approximately 60% of the industry is devoted to human health applications, 10% to agricultural biotechnology and 30% to industrial applications, bioinformatics and genomics. India has launched a national biotechnology development strategy focusing on biotechnology's potential to provide long-term benefits for agriculture, health and the environment. The strategy includes a target for the biotechnology industry to generate US$7 billion by 2012, and the revamping of biotechnology education programmes to create global centres of educational and research excellence. To achieve this target the country will boost funds for biotechnology by five-fold over the next five years, from 14,500 million Indian rupees (US$362 million) during 20022007 to 65,000 million Indian rupees (US$1.6 billion) by 2012. Regional support for the life science sector is also available to promote specific initiatives in areas where the Government is creating centres of excellence such as: ICICI Knowledge Park located in a 200 acre campus in the heart of Genome Valley. Hyderabad. This is the first state-of-the-art biotech cluster in India for life sciences research, training, collaboration and manufacturing activities. Spread over 600 sq km around the ICICI Knowledge Park, the SP Biotech Park and the ICRISAT Agri-business Incubator, the Genome Valley provides world-class infrastructure facilities to over 100 biotech companies. A large number of R&D and academic institutions in and around the biotech cluster contribute to the knowledge and talent pool. The 100-acre Bangalore Helix is designed to be a beacon for global biotech companies and house 50-100 big and small entities engaged in a variety of high-end activities, on the lines of the International Tech Park that drew IT companies in the 1990s. Some 20 acres has already been developed and houses the Institute of Bioinformatics and Applied Biotechnology. The latest version of the Millennium Biotech policy will promote 10 biotech finishing schools selected by the Association of Biotechnology Led Enterprises (ABLE) and the Vision Group on Biotechnology. The policy aims to establish five biotech parks in Mysore, Mangalore, Dharwad and Bidar, apart from the Bangalore Helix. The government will also initiate a Bio Venture Fund with a corpus of Rs50 crore The Government is focussing efforts on regulatory compliance and the latest manufacturing technologies for clean rooms to ensure that the regulatory authorities such as the FDA and MHRA are able to approve the manufacturing sites for the production of generic drugs, medical devices and diagnostic kits. The SCLSP has already identified around 46 target companies which is shown in Appendix A.

SWOT Analysis
Strengths Weaknesses

Approved suite of successful products Collaborative approach to delivery Experience of delivery overseas

Lack of presence in target markets Cost of delivery Lack of funding to deliver programme

Opportunities

Threats

Growing life science market in India Local need for Life science training Sector specific knowledge e.g. biofuels

Existing training providers New legislation (Foreign Educational Institutions Act 2011) Existing approval process (AICTE)

Regional Target Markets Overview

Bangalore Bangalore is now the fifth largest city in India, and has three universities, several engineering colleges and a plethora of well-reputed research institutes devoted to aeronautics and space, science, health and so forth. Biotechnology has emerged as a recent rapidly expanding sector in Bangalore. The city accounts for over 50% of the 370 biotech companies in India. Biocon, the nations leading biotech company is headquartered in Bangalore. Bangalore has opportunities in contract research space, bioinformatics (because of the IT influence) and lot of potential in the stem cell area. Gujarat (Vadodara and Ahmedabad) Gujarat has around 50 biotechnology companies and 66 support organisations. Over the years, the state has also evolved as the hub for pharmaceutical companies, which contributes to over 42 percent of Indias total turnover in the pharmaceutical sector and provide employment to 5,200 people. The state has around 3,267 registered units. Gujarats other strengths include agriculture biotechnology which includes companies like Bayer Crop Science Ltd and Excel Cropcare. The industrial biotechnology front major companies are Maps(India) Ltd, Anil Biochem Ltd, Americos Industries Inc and Zytex Biotech. Other areas include environmental biotechnology, bioinformatics, educational infrastructure and the upcoming marine biotechnology. Chandigarh It is forecast that more than half of India's pharmaceutical production, mainly formulations, would originate from this area in a few years from now as 200 odd medium and large-scale units are coming up in and around Baddi. Official sources claim Himachal is in the process of attracting investments to the tune of over GBP 600 million and the local Government is now working on a mission to convert the state into a leading bio-business valley of the country. Bhuvneshwar (Bhubaneswar) The local Government is focussing on biomass and renewable energy products rather than medical life sciences although it is also a centre for excellence in training and is emerging as a national educational hub. A number of new universities and institutes are to be established in the area to complement the 40 existing engineering colleges. Hyderabad Hyderabad has over 100 biotech companies including 53 International biotech companies in operation. They have established, in special 100 acre site for the preclinical research, the Biotechnology Incubation Centre (BTIC) to foster the growth of start-up companies through provision of specialised facilities and the International Life Sciences Institute in 20 acres of land to provide training in the advanced research in pharma and drug discovery. They also plan the: establishment of Institute of Life Sciences at University of Hyderabad a Marine Biotech Park at Visakhapatnam to focus on marine foods and fisheries a world class research facility for conservation of Endangered Species (LaCONES) in partnership with CCMB Agri-Science Park and Agri-Business Incubator at ICRISAT Indira Gandhi Centre for Advanced Research on Livestock in Kadapa District to promote Livestock vaccines and products setting-up of International Animal Resource Facility in collaboration with Indian Council for Medical Research (ICMR) & National Institute of Nutrition (NIN) in Genome Valley.

Competition
The UKTI and EDUKS reports have identified a number of potential competitors for this market. These reports are appended as Appendix B and C. A full list by region can be seen in the attached reports and the key points are reproduced below: Edexcel has been in India for 10 years working with a number of training providers to deliver both academic and vocational qualifications IndiaCan is a joint venture between Educomp solutions and Pearson Inc. Their primary focus is on developing content although they are also active in delivery City & Guilds have an office in Dehli and are establishing a JV with the Manipal group which is called India Skills. They plan to deliver a wide range of skills training across all sectors TAFE (Australia) offer transnational courses through 4 centres in India as well as running courses in Australia. Recently they have signed an agreement with Everonn Education in Chennai to deliver skills programmes across the country Learning Skills Network (UK) and Career Launchers are looking to create a partnership to provide trainers. None of these organisations appear to have any focus on life sciences and the possibility of collaboration with local providers such as Everonn, Manipal and Career Launchers emphasises the opportunity for SCLSP to establish themselves as a leading provider of training in this sector.

Track Record
Colleges in Scotland have significant experience of working in partnership on development funded projects to improve the employability of students in Scotland and internationally. In particular, many of the partner colleges in SCLSP have worked together in previous projects and with Scottish universities. Three notable projects are: SCBC (2004-2008) a project which developed many online materials that will be of use to international clients and also delivered pre-bio courses to industry Skills Utilisation Project (current) aims to develop a skills ecosystem in Scotland with colleges working together with universities and industry in the life sciences field Modern Apprenticeship (MA) The partnership works with employers to develop the skills of their workforce and so improve competitiveness. They are developing a new MA programme in life sciences together with SEMTA (the Sector Skills Council for the life sciences industry in the UK). They have worked with many companies including Glaxo Smithkline, Invitrogen, Lifescan, DSM Nutritionals, Bioreliance, the National Health Service (NHS), Scottish Water and local government authorities. The partners work with international partners to deliver life sciences subjects and develop new programmes. In the field of life sciences in particular they have experience of working in India, Botswana and Libya. Colleges in Scotland have relationships with educational institutions, companies, agencies and governments in countries including India, China, USA, many countries in Africa, the Middle East and across Europe. They have led on significant capacity-building initiatives to develop education infrastructure including the highly successful Equipping Vocational Education and Training Staff (EVETS) project in Malawi.

Financial Summary
Their basic business model involves building up a market presence through collaborations in development funded initiatives with educational institutes. They will build a reputation for an open

and trustworthy approach to partnership that is based on supporting their partners to develop their own capacity. They expect that their partners will be pleased to recommend their services and provide good references that will help them to grow the business. Whilst SCLSP are public funded organisations, there is a clear imperative to return contributions to overheads for the colleges in the medium term in order to make the venture worthwhile. It is expected that such returns, however, will take some investment to achieve in terms of staff time input to development funded projects that will contribute to market presence. The business year runs from April to March and the three year results are summarised below: Year 1 35,200 40,400 (5,200) 5,200 Year 2 93,480 123,900 (30,420) 52,400 Year 3 128,530 73,100 55,430 27,800 Totals 257,210 237,400 19,810 85,400

Income Expenditure Contribution to overheads Investment Grant support

The financial plan is shown in Appendix D.

Management Structure
The lead college of the SCLSP during the term of ALLIES funding is Dundee College, represented by Dr David Gourley. The partners have agreed to establish a Scotlands Colleges generic e-mail address to be used in any marketing materials that will be monitored by the lead college. Marketing support is available from Dundee College for the partnership as agreed by the Strategic Committee. It seemed sensible that each group member could access this support from their own organisation rather than a central dissemination group. The ALLIES project has considered the issues surrounding sharing business opportunities at a project level and a Model for Collaborative Working has been established which includes: a Statement of Accord for colleges to sign-up to. This statement is a code of conduct agreeing that a contact introduced to the group for a collaborative project will not be approached by other partners a fair and transparent process for selecting partners for business projects, which includes identification of a lead role for projects. pricing guidelines to support the development of collaborative bids and tenders a basis for sharing IPR resulting from materials or products developed in joint business projects. Beyond the project term, the partners will elect a lead each year and the partners have agreed to continue to circulate opportunities according to the model. A detailed training and development catalogue for life sciences is shown in Appendix E.

Appendix A Target Companies

The SCLSP has already identified around 46 target companies which are shown below: Ahmedabad Address Zydus Cadila Cadila Healthcare Ltd Zydus Tower Satellite Cross Roads Ahmedabad 380015 Contact: Mr P R Joshi, Head Human Resource Tel: 91 79 26868100 Email: prjoshi@zyduscadila.com Website: www.zyduscadila.com Cadila Pharmaceuticals Ltd Cadila Corporate Campus Sarkhej-Dholka Road Bhat Ahmedabad 382210 Contact: Mr Narendra Vyas, Head Human Resources Tel: 91 2718 225001 Email: narendra.vyas@cadilapharma.co.in Website: www.cadilapharma.com Torrent Pharmaceuticals Ltd Off. Ashram Road Ahmedabad 380 009 Contact: Mr Ketan Bhatt, Head Human Resources Tel: 91 79 26585090/3060 Email: ketanbhatt@torrentpharma.com Website: www.torrentpharma.com Dishman Pharmaceuticals and Chemicals Ltd Bhadr-Raj Chambers Swastik Cross Road Navrangpura Ahmedabad 380 009 Contact: Mr Arvind Joshi, Head Human Resources Tel: +91(79) 26443053/26445807/26560089 Email: dishman@dishmangroup.com Website: www.dishmangroup.com Intas Biopharmaceuticals Ltd. Plot No. 423/P/A/GIDC Sarkhej - Bavla Highway Moraiya, Taluka Sanand Ahmedabad 382 210 Contact: Mr Anil Tyagi, Head HR Tel: 91 79 66112501 Email: anil.tyagi@intasbiopharma.co.in Website: www.intasbiopharma.co.in

Concord Biotech Limited B-1002 Safal Pegasus 10th Floor Nr. Prahladnagar Garden 100ft Road Satellite Road Ahmedabad 380015 Contact: Mr Devang, Head HR Tel: 91 79 40321179 Email: concord@concordbiotech.com Website: www.concordbiotech.com Maps (India) Limited 302, Shapath-3 Near GNFC Info Tower S.G. Road Ahmedabad 380054 Contact: Mr Bhavin Bhalkiwala, Head Human Resources Tel: +91 (79) 26859971-74 Email: careers@mapsenzymes.com Website: www.mapsenzymes.com Anil Products Limited Anil Road P.O. Box 10009 Ahmedabad 380025 Contact: Ms Kalpana Pareekh, Head Training Tel: 91-79-2220 3222 Email kalpana.pareekh@anil.co.in Website: www.anil.co.in Quintiles Research (India) Private Limited B - 101 -106 Shapath IV Opp. Karnavati Club Sarkhej-Gandhinagar Road Ahmedabad 380 051 Contact: Ms Hufriz Karkeria, Head HR Tel: 91 79-6630 3300 Website: www.quintiles.com Bangalore Biocon Ltd 20th KM Hosur Road Electronics City Bangalore 560 100 Contact: Kiran Mazumdar Shaw Tel: 91 80 2808 2808 Email: contact.us@biocon.com Website: www.biocon.com Novo Nordisk India Limited Plot No.32 47-50, EPIP Area Whiltefield Bangalore 560 066 T: +91 80 4030 3200 Email : prindia@novonordisk.com Website: www.novonordisk.co.in

10

Syngene International Biocon Park Plot 2&3 Bommasandra Industrial Estate - Phase-IV Bommasandra-Jigani Link Road Bangalore 560 099 Tel: 91 80 2808 2808 Website: www.syngeneintl.com Strides Arcolab Limited Strides House Bilekahalli Bannerghatta Road Bangalore 560076 Contact: Mr Balachander Tel: +91 80 66580000 Email: balachander.n@stridesarco.com Website: www.stridesarco.com Micro Labs Limited No.27 Race Course Road Bangalore 560 001 Contact: Mr Shivaji Kapade, Head HR Tel: +91 80 22370451 Email: shivaji.kapade@microlabs.in Website: www.micorlabsltd.com Medreich Medreich House 12/8 S.A. Street MS Nagar Bangalore 560033 Contact: Mr Reny Samuel Tel: +91 80 2549 1545 Email: reny.s@medreich.com Website: www.medreich.com AstraZeneca India Pvt. Ltd Bellary Road Hebbal Bangalore 560 024 Contact: Mr Manoj Singalachar Tel: +91-80-23621-212 Email: manoj.sincalachar@astrazeneca.com Website: www.astrazeneca.com Himalaya Drug Company Makali Bangalore 562123 Contact: Mr Raghavendra Kulkarni, Learning Development Manager Tel: +91 80 2362 1212 Email: raghu.kulkarni@himalayahealthcare.com Website: www.himalayahealthcare.com Bioplus Life Sciences Pvt Ltd Pharmed Gardens Whitefield Road Bangalore 560 048 Contact: Mr Kumaraguru Tel: +91 80 28410158 Email: kumaraguru@bioplus.com Website: www.bioplus.com

and

11

Anglo-French Drugs & Industries Ltd 41, 3rd Cross 5th Block Rajajinagar Bangalore 560010 Contact: Mr Ravishankar, Head Quality Control Tel: +91 80 23154770 Email: Ravishankar.v@afdil.com Website: www.afdil.com Bal Pharma Limited 5th Floor Laxmi Narayan Complex 10/1, Palace Road Bangalore 560 052 Contact: Mr Kotian Tel: +91 80 4137 9500 Email: kotian@balpharma.com Website: www.balpharma.com Strand Life Sciences 5th Floor Kirloskar Business Park Bellary Road Hebbal Bangalore 560024 Contact: Ms Radhika Choudhary Tel: +91 80 4078 7263 Email: radhika@strandls.com Website: www.strandls.com Chandigarh Parabolic Drugs Limited SCO 99-100 Sector 17-B Chandigarh Contact: Mr Pranav Gupta, Managing Director Tel: +91 172 391 4646 Email: Pranav.Gupta@parabolicdrugs.com Website: www.parabolicdrugs.com Nectar Lifesciences Limited SCO. 38-39 Sector 9-D Chandigarh 160009 Contact: Mr Dinesh Dua, CEO & Director Tel. +91 172 3047766 Email: dinesh.dua@neclife.com Website: www.neclife.com Venus Remedies Limited 51-52 Industrial Area - Phase 1 Panchkula (Haryana) 134 113 Contact: Ms Monica, Business Development Manager Tel: +91 172 393 3090 Email: intlmonica@venusremedies.com Website: www.venusremedies.com

12

Ind-Swift Laboratories Ltd S.C.O. 850 Shivalik Enclave Manimajra Chandigarh 160101 Contact: Dr Lalit Wadhwa, Associate Director Tel: +91 172 2730503 E-mail: lalit.wadhwa@indswiftlabs.com Website: www.indswiftlabs.com Chennai Rasi Seeds (P) Ltd 273, Kamarajanar Road P.O. Box No: 30 Attur 636 102 Salem District Tamilnadu Tel: +91-4282-241007 Email: rasimail@rasiseeds.com Website: www.rasiseeds.com Goa Kare Labs Pvt Ltd L- 40 Verna Industrial Estate Verna Goa 403 722 Contact: Mr Dinar Mardolkar, General Manager Human Resources Tel: 91(832) 2783469 Email: dinor@karelab.co.in Website: www.karelab.co.in Wallace Pharmaceuticals Ltd 3rd Floor Dempo Trade Centre Bldg Patto Plaza EDC Complex Panaji 403001 Contact: Ms Shruti Mhatri, HRD Tel: +91 22 2839 0681/2/3/9/0730 Email: shruti@wallacepharma.net Website: www.wallacepharma.net Geno Pharmaceutical Ltd Pharmaceutical Complex Tivim Industrial Estate PO Karaswada Mapusa Goa 403 536 Contact: Mr V L Sawant, Human Resources Manager Tel: 91 832 2257216/7 Email: personnel@genopharma.com Website: www.genopharma.com

13

Hyderabad Nuziveedu Seeds Limited NSL ICON 4th Floor Road No: 12 Banjara Hills Hyderabad 500 034 Tel: 91-40-30514444 Email: info@nuziveeduseeds.co.in Website: www.nuziveeduseeds.com Shantha Biotech H.No.5-10-173, 3rd & 4th Floors Vasantha Chambers Fateh Maidan Road Basheerbagh, Hyderabad 500 004 Tel: +91 40 23234136 E-mail: info@shanthabiotech.co.in Website: www.shanthabiotech.com Bharat Biotech Genome Valley Shameerpet Hyderabad 500 078 Tel: +91 40 2348 0567 Email: info@bharatbiotech.com Website: www.bharatbiotech.com Indian Immunologicals Ltd Road # 44 Jubilee Hills Hyderabad 500033 Contact: Dr. G.S. Reddy Email: gsr@indimmune.com Website: www.indimmune.com Mumbai Vicco Laboratories 25 Jerbai Wadia Road Bhoiwada Parel Mumbai 400 012 Contact: Mr P Y Palwankar, Managing Director (Human Resource Head) Tel: +91 22 24147780 Email: pyp@viccolabs.com Website: www.viccolabs.com Indoco Remedies Limited Indoco House 166 CST Road Santacruz (East) Mumbai 400 098 Contact: Ms. Aditi Kare Panandikar, Director - Business Development & HRD Tel: +91-22-2654 Email: hrd@indoco.com Website: www.indoco.com

14

Blue Cross Laboratories Ltd Peninsula Chambers Ground Floor Ganapatrao Kadam Marg Lower Parel (West) Mumbai 400013 Contact: Mr. Dolfred Furtado, Personnel Director Tel: 91 22-6663 8000 Email: dolfred@bluecrosslabs.com Website: www.bluecrosslabs.com Ratiopharm India Private Limited 402 Omega Hiranandani Business Park Powai Mumbai 400 076 Tel: +91 22 6641 2100 Email: contact@ratiopharm.in Website: www.ratiopharm.in Cipla Ltd 289 Bellasis Road Sahil Hotel Mumbai Central East Mumbai 400 008 Contact: Mr S V Iyer, Head Human Resources Tel: 91 22 23082891 Email: gloria.dsouza@cipla.com Website: www.cipla.com Aventis Pharma Ltd (Sanofi-Aventis Group) Aventis House, 54/A Sir Mathuradas Vasanji Road Andheri East Mumbai 400 093 Contact: Mr Pradeep Vaishnav, Head Human Resources Tel: 91 22 2827 8000 Email: pradeep.vaishnav@sanofi-aventis.com Website: www.aventispharmaindia.com Unichem Laboratories Ltd Unichem Bhavan Prabhat Estate S V Road Jogeshwari (W) Mumbai 400 102 Contact: Mr Prasad Joshi, Head Human Resources Tel: 91 22 6688 8333 Email: Prasadjoshi@unichemindia.com Website: www.unichemindia.com Excel Crop Care Limited 13, Aradhana Industrial Development Corporation Near Virwani Industrial Estate Goregaon East Mumbai 400063 Contact: Mr N K Amin, Human Resources VP Tel: 9122-42522200 Email: amin@excelcropcare.com Website: www.excelcropcare.com

15

New Delhi Panacea Biotec B-1 Extn/G-3 Mohan Co-op. Industrial Estate Mathura Road New Delhi 110044 Tel: +91-11-26945270 Email: hrd@panaceabiotec.com (HR) Website: www.panacea-biotec.com Pradesh Morepen Laboratories Ltd Morepen Village Nalagarh Road Near Baddi District Solan Hiamchal Pradesh 173220 Contact: Maj Upwan Kulshreshta, Head HR &Training Tel: +91 1792 233284 / 233286 Email: upwan.kulshreshta@morepen.com Website: www.morepen.com Pune Serum Institute of India Ltd 212/2 Hadapsar Off Soli Poonawalla Road Pune 411028 Contact: Mr Rammesh Patil, HR Tel: +91-20-26993900 Email: serumexports@vsnl.com Website: www.seruminstitute.com Vadodara Alembic Ltd Alembic Road Vadodara 390003 Contact: Mr Chirayu R Amin, Chairman & Managing Director Tel: 91 265-2280550 Email: alembic@alembic.co.in Website: www.alembic-india.com Gujarat Life Sciences 9, Krishna Estate Gorwa Baroda 390 016 Contact: Mr Rajesh Umatt, Chief Operating Officer and HR Head Tel: +91-265-2285611 Email: info@glsbiotech.com Website: www.glsbiotech.com

16